This Quality Improvement (QI) Program aims to improve the management of patients with chronic heart failure with a LVEF (left ventricular ejection fraction) lower than 40%.
On 1 August 2018, updated guidelines for prevention, detection and management of heart failure were released by the National Heart Foundation of Australia and Cardiac Society of Australia and New Z
Heart failure is a significant health issue in Australia, with complex diagnostic and management methods that must be tailored to each patient. This ALM comprehensively covers the many stages of heart failure management including the identification of risk factors, diagnosis and investigations, pharmacological and non-pharmacological management, management of progression and comorbidities, the use of implantable devices and end-of-life care, and multidisciplinary care programs.
Heart failure is a significant health issue in Australia with a mortality rate comparable to the common forms of cancer, but early detection and management can significantly improve patient outcomes. This module outlines the signs and symptoms of heart failure, and the screening of individuals with increased risk factors.
This is one module in the Heart Failure in General Practice series.
Click here to view all modules in this series.
Early investigation is critical to determining the cause of heart failure, its mechanism and any exacerbating factors, allowing for management to be optimised for each patient. This module explores the diagnostic investigations essential for heart failure including echocardiography, ECG, chest X-ray and blood tests, as well as guidance on interpreting results.
Pharmacological therapies are central to both the prevention of heart failure in high risk groups and the ongoing management of existing HF. This module covers the evidence-based pharmacological therapies for heart failure and the management of the risk of HF progression.
Non-pharmacological management is essential for the management of heart failure, and patient education is crucial for effective self-management. This module explores the many non-pharmacological management options for HF both in the general practice and patient self-care settings, highlighting the roles that multidisciplinary health professionals can take.
The management of exacerbating factors and comorbidities to maintain quality of life is an important component of heart failure management. This module outlines ways to identify and control exacerbating factors and comorbidities that may affect HF, and explores the role of non-surgical devices and end-of-life care.
Multidisciplinary care can prevent heart failure in people at risk, prolong survival, reduce hospital admissions and improve quality of life. This module explores the effective use of multidisciplinary care for heart failure management, including the preparation of short and long-term management plans and referral to other health professionals.